Page 227 - ASHG 2013 Program Guide

ednesday authors will present; T=Thursday authors will present; F=Friday authors will pr
F Disease status and genetic testing among
consumers of two personal genomics companies:
Findings from the PGen Study.
S. F. Meisel, J. Wardle,
J. Mountain, T. Moreno, S. S. Kalia, J. S. Roberts, R. C.
Green, for PGen Study Group.
F Pathways to and through genetic testing and
cancer aged 18-25.
L. M. Hoskins, A. Werner-Lin.
F Moving up mastectomies: Emerging adulthood,
surveillance fatigue and the Affordable Care Act of
A. Werner-Lin, L. Hoskins.
F High satisfaction and low distress after diagnostic
whole exome sequencing in adults.
N. Hoogerbrugge, A.
S. Sie, W. A. G. Zelst-Stams, M. R. Nelen, H. G. Yntema, L.
Spruijt, J. A. Veltman, I. Feenstra, J. B. Prins.
F A study of perception of health problems in
patients with Prader-Willi syndrome by their caregivers
and the caregivers’ health care behaviors.
W. Khunin, P.
Tanpowpong, D. Wattanasirichaigoon.
F Is it “just like any other test?”: Parents
experiences with array cGH in pediatrics.
R. Babul-Hirji,
N. Hoang, R. Hayeems, R. Weksberg, C. Shuman.
F Impact of a brief theory-driven intervention on
family communication about cancer family history
in a diverse urban clinic.
J. Bodurtha, D. Bowen, J.
Borzelleca, R. Corona, M. Gyure, A. Krist, A. Maibauer, D.
McClish, V. Rodriguez, J. Quillin.
F Cancer genetics referral patterns of physicians
and patient socio-demographics.
J. Cohn, W. Blazey,
S. Koehler, B. Laurent, V. Chan, M. Jung, D. Tegay, B.
F Prenatal chromosome SNP microarray analysis:
Genetic counseling issues and dilemmas.
H. Cabral, S.
Schwartz, J. Tepperberg, I. Gadi, V. Jaswaney, R. Burnside,
K. Phillips, E. Keitges, H. Risheg, V. Potluri, R. Pasion, B.
Rush, H. Taylor, L. Kline, J. Shafer, P. Papenhausen.
F Offspring risk perceptions: Adolescents and
young adults with congenital heart disease agree with
their parents (and both are wrong!).
S. M. Fitzgerald-Butt,
K. M. Fry, A. N. Zaidi, C. A. Gerhardt, V. Garg, K. L. McBride.
F Emerging changes in genetic counseling and
reproductive decision making based on AGG mapping
of fragile X carriers.
A. G. Hadd, A. Glicksman, J.
Coppinger, N. Ersalesi, J. McCarver, E. Blatt, W. T. Brown,
J. Skeen, G. J. Latham, S. L. Nolin.
F A two-stage approach to genetic risk prediction
of breast and ovarian cancer.
P. M. Atienza, J. Chipman,
K. Hughes, C. I. Amos, B. Arun, G. Parmigiani, S. Biswas.
F Clinical implications of variants of unknown
significance in ch omosomal microarrays in pregnancies
in Israel.
H. Yonath, S. Rienstein, J. Shamash, M.
Berkenstadt(, M. Dicastro, S. Eisenberg- Brazilai, N.
Goldstein, M. Frydman, E. Pras.
F A gift to the children — Genetic testing at the
end of life.
M. Mikhaelian, K. Stears.
T A historical overview and a reflection on bioethica
and ELSI activities for basic researches in human
genetics and genomics in Japan.
N. Yamamoto, K. Kato.
W Result of the bioethics questionnaire survey
of Nepali university students on genetic testings.
H. Numabe, R. Pokharel.
T Attitudes and concerns of educated scientists
undergoing whole exome sequencing.
A. Fiksdal, N.
Lindor, K. Johnson, K. Hunt, K. Mensink, J. McCormick.
Genetic Counseling
F Parental decisions following prenatal diagnosis
of chromosomal abnormalities around Nagoya, Japan.
N. Suzumori, K. Kumagai, S. Goto, A. Nakamura, S.
Saitoh, M. Sugiura-Ogasawara.
F Parental causal attributions of OCD and
implications for genetic counseling: An exploratory
H. J. Andrighetti, A. Semaka, S. E. Stewart, C.
Shuman, D. Chitayat, R. Hayeems, J. C. Austin.
F An exploration of families’ experiences
regarding a comorbid diagnosis of neurofib omatosis
type 1 and autism spectrum disorder in their child:
Guiding screening and disclosure practices.
L. Baret,
R. Hayeems, P. Parkin, C. Shuman, M. Carter, P. Kannu,
D. Chitayat, A. Shugar.
F Perspectives of adolescents regarding their
genetic counseling experience: A qualitative study.
A. Pichini, K. Sappleton, M. Kaufman, C. Shuman, D.
Chitayat, R. Babul-Hirji.
F Reproductive genetic counseling — The most
suitable timing?
N. Takeshita, A. Takashima, Y. Yasuda, T.
Adachi, I. Sasaki, K. Yokokawa, M. Manrai, T. Ichinose, A.
Ishida, M. Urita, A. Yokoyama, T. Kinoshita.
F Whole exome sequencing: Assessing what
patients want to know.
K. Hitch, G. Joseph, J. Guiltinan,
J. Kianmahd, J. Youngblom, A. Blanco.
F Parents’ understanding of uncertain chromosomal
microarray results: A search for meaning.
L. A.
Kiedrowski, K. M. Owens, B. M. Yashar, J. L. Schuette.
F Comparing uptake of testing and psychosocial
impact in pregnant and non-pregnant women offered
carrier screening for fragile X syndrome.
S. Metcalfe, M.
Martyn, J. Emery, J. Halliday, S. Donath, J. Cohen, FaXeS
Study Team.
F A study in contrasts: The effect of personal
genomic testing on perceived risk of melanoma and
lung cancer in the PGen Study.
D. A. Carere, P. Kraft,
C. A. Chen, L. A. Cupples, T. Moreno, J. Mountain, J. S.
Roberts, R. C. Green, PGen Study Group.
F Genetic testing for cardiovascular risk can promote
better control over controlled risk factors during one year
follow up in women.
O. A. Makeeva, V. V. Markova.